These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 15038944

  • 1. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
    Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D.
    Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
    [Abstract] [Full Text] [Related]

  • 2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 3. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 4. Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine.
    Barbanti P, Carpay JA, Kwong WJ, Ahmad F, Boswell D.
    Curr Med Res Opin; 2004 Dec; 20(12):2021-9. PubMed ID: 15701219
    [Abstract] [Full Text] [Related]

  • 5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
    Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J.
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [Abstract] [Full Text] [Related]

  • 6. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ, Alexander WJ, Spruill SE, Barrett PS, Lener SE.
    JAMA; 2007 Apr 04; 297(13):1443-54. PubMed ID: 17405970
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 04; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
    Cady RK, McAllister PJ, Spierings EL, Messina J, Carothers J, Djupesland PG, Mahmoud RA.
    Headache; 2015 Jan 04; 55(1):88-100. PubMed ID: 25355310
    [Abstract] [Full Text] [Related]

  • 9. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.
    Arch Fam Med; 1998 Jan 04; 7(3):234-40. PubMed ID: 9596457
    [Abstract] [Full Text] [Related]

  • 10. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial.
    Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait DG.
    Arch Intern Med; 1998 May 11; 158(9):1013-8. PubMed ID: 9588435
    [Abstract] [Full Text] [Related]

  • 11. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr 11; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 12. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group.
    Headache; 2001 Sep 11; 41(8):745-53. PubMed ID: 11576197
    [Abstract] [Full Text] [Related]

  • 13. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J.
    Headache; 2015 May 11; 55(5):621-35. PubMed ID: 25941016
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr 11; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 15. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May 11; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets.
    Savani N, Pfaffenrath V, Rice L, Boswell D, Black L, Jones M, Sumatriptan SUMB4007 Study Group.
    Clin Ther; 2001 Feb 11; 23(2):260-71. PubMed ID: 11293559
    [Abstract] [Full Text] [Related]

  • 17. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.
    Winner P, Mannix LK, Putnam DG, McNeal S, Kwong J, O'Quinn S, Richardson MS.
    Mayo Clin Proc; 2003 Oct 11; 78(10):1214-22. PubMed ID: 14531480
    [Abstract] [Full Text] [Related]

  • 18. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Oct 11; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 19. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH.
    Neurology; 2000 Jan 11; 54(1):156-63. PubMed ID: 10636142
    [Abstract] [Full Text] [Related]

  • 20. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May 11; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.